A 77-year-old woman, previously maintained on phlebotomies that had been discontinued 3 years before for a purported diagnosis of iron overload, was assessed for normocytic normochromic anemia. Her blood count showed hemoglobin of 90 g/L (normal: 115-160), mean corpuscular volume of 93.2 fL (normal: 79-97), erythrocyte distribution width of 28.1% (normal: 12%-15%), and platelets of 422x10 9 /L (normal: 150-400). Iron studies showed elevated ferritin (491 µg/L; normal: 13-150), total iron of 14 µmol/L (normal: 7-26), transferrin saturation of 32% (normal: 11%-56%), and unsaturated iron binding capacity of 30 µmol/L (normal: 19.7-66.2). The vitamin B6 level was low (<10 nmol/L; normal: 20-96). HFE C282Y, H63D, and JAK2 V617F mutations were negative. The peripheral blood smear showed marked anisopoikilocytosis ( Figure 1A ; Wright's stain, 40 x ). A
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